Clinical & Translational Research

Dr. Mitreva is an internationally acclaimed scientist who leads a basic and translational research program studying neglected tropical diseases, specifically helminth infections. Her enduring dedication to enhancing omics-driven discoveries and their clinical applications is paving the way for long-lasting improvements in global health.

Dr. Mittal specializes in the intricate dynamics of host-pathogen interactions, with a particular emphasis on the innate immune response to Mycobacterium tuberculosis (Mtb).

His overarching research interests are in utilizing implementation science and epidemiologic methods to better understand how to deliver high-quality and patient-centered HIV care in routine practice resource-limited settings

Dr. Olsen’s primary research interests involve the epidemiology of hospital-acquired infections, particularly surgical site infection, and the use of administrative and claims data to study surgical complications.

Areas of Interest in ID:
Host pathogen interaction in bacterial pathogenesis

Dr. Pal specializes in HIV basic science and translational research. She additionally runs an HIV cure trial out of the Infectious Disease clinical research unit (ID-CRU) and serves on the inpatient infectious disease consult service.

Dr. Pande specializes in the care of transplant recipients, with a special focus on opportunistic infections and antimicrobial prophylaxis in bone marrow transplant recipients.

Dr. Parra-Rodriguez specializes in the longitudinal clinical care of people with HIV, with a special clinical research focus on aging, age-related clinical conditions, and mental health in people with HIV.

Dr. Philips is principal investigator of an NIH-funded lab that studies how Mycobacterium tuberculosis evades the host immune response.

Dr. Pinzone’s interests are HIV, TB and viral infections in immunocompromised hosts.

Dr. Poowanawittayakom interests are in bone and joint infection, infection prevention/control, hepatitis C, emerging infectious diseases, and global health.

Dr. Powderly has been actively involved in HIV-related clinical research for over thirty years with specific interests in opportunistic infections, metabolic complications and long-term outcomes of antiretroviral therapy.

Dr. Presti specializes in clinical and translational research in infectious disease, with a special focus on HIV, SARS-CoV-2 and other viral infections.

Dr. Ramakrishnan’s research focuses on applying implementation science strategies to improve domestic HIV prevention and care, particularly for cisgender women.

Dr. Rauseo specializes in clinical infectious diseases, with a special focus on mycology and infectious that affect immunocompromised hosts. Since the outset of the COVID-19 pandemic she has served as an investigator in the Infectious Disease Clinical Research Unit (ID-CRU) in multiple clinical trials and translational research in the fight against COVID-19.

Dr. Reno specializes in sexual health care, with a special focus on the clinical care of sexually transmitted infections (STI) and the intersection with HIV prevention.

Dr. Rosa’s experience in the statistical analysis of complex datasets (utilizing multiple types of evidence spanning treatments or species) has led to the identification differentially expressed genes, drug targets and pathways of interest for experimental verification.

Dr. Sayood performs clinical research with a specific focus on antimicrobial stewardship and clinical decision support.

Dr. Spec‘s research is in fungal infections, particularly in immunocompromised patients, including those with transplants. His research focuses on Cryptococcus, Histoplasma, Candida, Aspergillus and other invasive molds. Dr. Spec also runs the division’s clinic focusing on invasive fungal infections, where he takes care of both immunocompromised and immunocompetent patients with fungal infections, which he considers the best and most rewarding part of his job.

Dr. Sung recently completed a two year fellowship in ID. She will continue to stay on in ID to continue her work on outpatient infection prevention, occupational health and medical education.

Why did you choose WashU for your ID fellowship?
I chose WUSM for fellowship training because of: the flexibility in career paths (very accommodating for people who don’t know what specific realm of ID they want to pursue), the abundant research opportunities, the awesome people, being able to walk to work, the giant hospital with its wide array of disease pathology and large referral radius.